As asset managers look to Asia for alpha, analytics & visualization tools take center stage

PineBridge Investments uses economic and time-series data analytics provider Macrobond Financial to better its economics research, which supports its portfolio managers and the firm’s overall investment thesis.

At a time when asset managers are struggling to find alpha due to fee compression and competition coming from passive strategies, as well as increased regulatory pressures in the US and Europe, some buy-side firms are looking to grow their presence in Asia by finding still-untapped or under-explored markets.

While “investing in Asia” is easily said, there are significant barriers that still exist. First, the market is incredibly fragmented, especially when compared with the US, the UK, and the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Back to basics: Taxonomies, lineage still stifle data efforts

Voice of the CDO: While data professionals are increasingly showing their value when it comes to analytics and AI adoption, their main job is still—crucially—getting a strong data foundation in place. That starts with taxonomies and lineage.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here